반코마이신 내성 장알균 집락이 확인된 환자를 격리해야 하는가?|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Vancomycin-resistant enterococci (VRE) are one of the most important pathogens causing healthcare-associated infections. If VRE is detected in the culture tests of a patient’s clinical specimen, the patient should be isolated in a single room (preferred to a cohort room), and contact precautions should be initiated based on the infection control guidelines for multidrugresistant organisms by the Korea Disease Control and Prevention Agency. VRE is known to transmit vancomycin resistance genes to other bacteria; hence, isolation of VRE-colonized patients is recommended. However, many studies have shown that the probability of the spread of vancomycin resistance genes from VRE to other bacteria is rare and that the discontinuation of isolation and contact precaution does not significantly increase the rate of VRE colonization or infection. Notably, the healthcare qualities for diagnosis and treatment were more improved in the group without isolation than in the group with isolation. Further investigations on the effects of discontinuing the isolation of VRE-colonized patients are warranted, because the characteristics of the Korean healthcare system are distinct from those of other countries. The study designs of quasi-experimental studies, which do not require randomization for analysis, would be useful in conducting studies on the effects of discontinuing the isolation of VRE-colonized patients. Considering the results of the previous and future studies and the unique features of the Korean healthcare system, the isolation protocols could be relaxed gradually and applied only to specific cases, such as residents of nursing hospitals and immunosuppressed patients.

번역하기

참고문헌 (Reference)

1 강지연, "일 대학병원 간호사의 다약제 내성균 감염관리지침에 대한 지식과 수행정도" 한국간호과학회 39 (39): 186-197, 2009

2 김유정, "요양병원 감염관리 현황 및 감염관리 담당자의 중요도 인식 조사" 한국산학기술학회 18 (18): 466-475, 2017

3 Gysin DV, "Variability in contact precautions to control the nosocomial spread of multi-drug resistant organisms in the endemic setting: a multinational cross-sectional survey" 7 : 81-, 2018

4 Vehreschild MJGT, "Vancomycin-resistant enterococci (VRE):a reason to isolate?" 47 : 7-11, 2019

5 O’Driscoll T, "Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management" 8 : 217-230, 2015

6 Walters MS, "Vancomycin-resistant Staphylococcus aureus - Delaware" 64 : 1056-, 2015

7 de Niederhäusern S, "Vancomycin-resistance transferability from VanA enterococci to Staphylococcus aureus" 62 : 1363-1367, 2011

8 Hemming K, "Use of multiple period, cluster randomised, crossover trial designs for comparative effectiveness research" 371 : m3800-, 2020

9 Rossi F, "Transferable vancomycin resistance in a community-associated MRSA lineage" 370 : 1524-1531, 2014

10 McDonald EG, "Timeseries analysis of health care-associated infections in a new hospital with all private rooms" 179 : 1501-1506, 2019